Sort by:
Filters:
In the last seven days, 170 new articles where published in 25 top journals in the field of medicine general internal.
Major topics on this page:
Lancet (London, England) | Review | 2025 Apr 12
Zaman S and Others
No abstract available
JAMA | Journal Article | 2025 Apr 15
Campo R
No abstract available
JAMA | Journal Article | 2025 Apr 15
Ammatuna E
No abstract available
JAMA | Journal Article | 2025 Apr 15
Aoun M and Others
No abstract available
JAMA | Journal Article | 2025 Apr 15
Tremblay D
No abstract available
Lancet (London, England) | Letter | 2025 Apr 12
Leibowitz R and Others
No abstract available
Lancet (London, England) | Letter | 2025 Apr 12
Al Zamel AM and Others
No abstract available
JAMA | Journal Article | 2025 Apr 15
Burns KEA and Others
No abstract available
JAMA | Journal Article | 2025 Apr 15
Andrea L and Others
No abstract available
JAMA | Published Erratum | 2025 Apr 15
No authors listed
No abstract available
JAMA | Journal Article | 2025 Apr 15
Bouchkouj N and Others
No abstract available
JAMA | Multicenter Study | 2025 Apr 15
Zhang X and Others
IMPORTANCE: Gastric cancer, including gastroesophageal junction cancer, is one of the most commonly diagnosed cancers worldwide, with high mortality. Sugemalimab is a fully human anti-programmed death-ligand 1 (PD-L1) antibody. The combination of sugemalimab and chemotherapy showed promising antitumor activity and safety in a phase 1b study among patients with treatment-naive, unresectable, locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma. This combination was further evaluated in the GEMSTONE-303 phase 3 trial.
JAMA | Journal Article | 2025 Apr 15
Yonis HGH and Others
No abstract available
Lancet (London, England) | Letter | 2025 Apr 12
Ayanda L and Others
No abstract available
JAMA | Journal Article | 2025 Apr 15
Edwards KM
No abstract available